CTOR · Citius Oncology Inc. Common Stock
View on chartInsiders & Stakes
| Leonard L. Mazur Chief Executive Officer | ▲ Buy | Grant | 1,700,000 Shares held | 9/19/2025 | View profile |
| Myron Czuczman Chief Medical Officer | ▲ Buy | Grant | 825,000 Shares held | 9/19/2025 | View profile |
| Jaime Bartushak Chief Financial Officer | ▲ Buy | Grant | 825,000 Shares held | 9/19/2025 | View profile |
| Joel David Mayersohn Director | ▲ Buy | Grant | 321,228 Shares held | 9/19/2025 | View profile |
| Dennis M. McGrath Director | ▲ Buy | Grant | 300,000 Shares held | 9/19/2025 | View profile |
| Robert Joseph Smith Director | ▲ Buy | Grant | 300,000 Shares held | 9/19/2025 | View profile |
| Carol Webb Director | ▲ Buy | Grant | 300,000 Shares held | 9/19/2025 | View profile |
| Suren G. Dutia Director | ▲ Buy | Grant | 300,000 Shares held | 9/19/2025 | View profile |
| Eugene Myron Holuka Director | ▲ Buy | Grant | 300,000 Shares held | 9/19/2025 | View profile |
| Myron Z. Holubiak Secretary | ▲ Buy | Grant | 100,000 Shares held | 9/19/2025 | View profile |
Transaction History
| Myron Z. Holubiak | ▲ Buy | Grant | 100,000 | $0 | 9/19/2025 |
| Joel David Mayersohn | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 |
| Suren G. Dutia | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 |
| Eugene Myron Holuka | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 |
| Myron Z. Holubiak | ▲ Buy | Grant | 850,000 | $0 | 9/19/2025 |
| Robert Joseph Smith | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 |
| Leonard L. Mazur | ▲ Buy | Grant | 1,700,000 | $0 | 9/19/2025 |
| Carol Webb | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 |
| Myron Czuczman | ▲ Buy | Grant | 825,000 | $0 | 9/19/2025 |
| Dennis M. McGrath | ▲ Buy | Grant | 300,000 | $0 | 9/19/2025 |
| Jaime Bartushak | ▲ Buy | Grant | 825,000 | $0 | 9/19/2025 |
| Joel David Mayersohn | ▼ Sell | Other | 21,228 | $0 | 7/28/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CTOR to Join October 2026 Investor Conferences
Citius Oncology announced it will take part in investor conferences scheduled for October 2026. The events give the company a platform to present its pipeline and business updates to potential investors. The stock is currently trading near its long‑term support level, which may be observed by attendees.
CTOR to Join October 2026 Investor Conferences. Citius Oncology announced it will take part in investor conferences scheduled for October 2026. The events give the company a platform to present its pipeline and business updates to potential investors. The stock is currently trading near its long‑term support level, which may be observed by attendees.